← All stories
Markets
Verici Dx (LSE:VRCI): Is Transplant Test Adoption Building Momentum This Week?
Highlights Shareholders approved a substantial share issue supporting the group's funding position. Ordering clinician numbers and onboarded transplant centres have both risen. Senior commercial hires and a clinical partnerships appointment…
Covered by 1 outlet
All coverage · 1 article